Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference21 articles.
1. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses;Barendsen;Int. J. Radiat. Oncol. Biol. Phys.,1982
2. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report;Brown;Int. J. Radiat. Oncol. Biol. Phys.,1984
3. Effect of cis-dichlorodiammine platinum II and X-rays on mammalian cell survival;Carde;Int. J. Radiat. Oncol. Biol. Phys.,1981
4. Reoxygenation in the RIF-1 tumor;Dorie;Int. J. Radiat. Oncol. Biol. Phys.,1984
5. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammine(II);Douple;Int. J. Radiat. Oncol. Biol. Phys.,1979
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of Swallowing Function in Patients with Head and Neck Squamous Cell Carcinoma in High vs. Low Dose Cisplatin;Cancer Investigation;2023-11-24
2. Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer;Pharmaceutics;2021-05-07
3. Optimal Administration Frequency of Cisplatin Concurrently With Radical Radiotherapy in the Definitive Treatment of Locally Advanced, Inoperable Squamous Cell Cancer of the Head and Neck. Still Obscured by Clouds?;Turkish Journal of Oncology;2020
4. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial;Journal of Clinical Oncology;2018-04-10
5. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data;The Oncologist;2017-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3